Results 1 - 10 of 68
Designing Multi-Target Drugs, Chapter 14 Discovery of HDAC-Inhibiting Multi-Target Inhibitors Xiong Cai, Changgeng Qian
, 2012
, Pages 221-242The Discovery and Utility of Chemical Probes in Target Discovery, CHAPTER 8 Chemical Probes for Kinases Xiaoyun Lu, Jeff B. Smaill, Ke Ding
, 2021
, Pages 182-213Kinase Drug Discovery, Chapter 5 Kinase Mutations and Resistance in Cancer Jack Andrew Bikker
, 2012
, Pages 126-160Designing Multi-Target Drugs, Chapter 11 Combination Agents Versus Multi-Targeted Agents – Pros and Cons Jose G. Monzon, Janet Dancey
, 2012
, Pages 155-180Conference on Drug Design and Discovery Technologies, Design and Synthesis of Some Novel Erlotinib Derivatives as Potential EGFR Kinase Inhibitors V. Ajeesh, S. Shubham, M. Ruchi
, 2020
, Pages 95-98Kinase Drug Discovery: Modern Approaches, CHAPTER 11 The Importance of Kinase Mutations in Cancer Drug Discovery Richard A. Ward, Frederick W. Goldberg
, 2019
, Pages 281-312MicroRNAs in Diseases and Disorders: Emerging Therapeutic Targets, CHAPTER 14 Strategies for Safe and Targeted Delivery of MicroRNA Therapeutics Sunghyun (Sander) Myoung, Andrea L. Kasinski
, 2019
, Pages 386-415The Chemistry and Bioactive Components of Turmeric, CHAPTER 12 Biological Activities of Non-curcuminoids Swee Keong Yeap, Wan Yong Ho
, 2021
, Pages 249-292Kinase Drug Discovery: Modern Approaches, CHAPTER 4 Covalent Inhibition of Kinases Gerjan de Bruin, Tjeerd Barf
, 2019
, Pages 61-96Kinase Drug Discovery: Modern Approaches, CHAPTER 6 The Design of Brain Penetrant Kinase Inhibitors Sarah E. Skerratt, R. Ian Storer
, 2019
, Pages 128-180